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Background: There are few studies describing periodic limb movement syndrome (PLMS) 
in rapid eye movement (REM) sleep in patients with narcolepsy, restless legs syndrome, REM 
sleep behavior disorder, and spinal cord injury, and to a lesser extent, in insomnia patients and 
healthy controls, but no published cases in multiple sclerosis (MS). The aim of this study was 
to investigate PLMS in REM sleep in MS and to analyze whether it is associated with age, sex, 
disability, and laboratory findings.
Methods: From a study of MS patients originally published in 2011, we retrospectively analyzed 
periodic limb movements (PLMs) during REM sleep by classifying patients into two subgroups: 
PLM during REM sleep greater than or equal to ten per hour of REM sleep (n=7) vs less than 
ten per hour of REM sleep (n=59). A univariate analysis between PLM and disability, age, sex, 
laboratory findings, and polysomnographic data was performed.
Results: MS patients with more than ten PLMs per hour of REM sleep showed a significantly 
higher disability measured by the Kurtzke expanded disability status scale (EDSS) (P=0.023). 
The presence of more than ten PLMs per hour of REM sleep was associated with a greater like-
lihood of disability (odds ratio 22.1; 95% confidence interval 3.5–139.7; P,0.0001), whereas 
there were no differences in laboratory and other polysomnographic findings.
Conclusion: PLMs during REM sleep were not described in MS earlier, and they are associ-
ated with disability measured by the EDSS.
Keywords: restless legs syndrome, spinal cord, sleep disorders, disability, clinical neurophysi-
ology, polysomnography
Introduction
Periodic limb movement syndrome (PLMS) can occur in a wide range of sleep disor-
ders such as restless legs syndrome (RLS), periodic limb movement disorder (PLMD), 
narcolepsy, and rapid eye movement (REM) sleep behavior disorder (RBD). PLMS 
has been reported in healthy subjects without any complaints as well.1–3 The Interna-
tional Classification of Sleep Disorders–Third Edition (ICSD-3), describes PLMS as 
periodic episodes of repetitive, highly stereotyped limb movements that occur during 
sleep, most frequently in the lower extremities and during nonrapid eye movement 
(NREM) sleep.1 The ICSD-3 states that PLMS is normally absent during REM sleep 
(except for RBD) as REM sleep is associated with atonia and an inhibition of motor 
phenomena.
If the periodic limb movement index (PLMI; the number of PLMs per hour of sleep) 
exceeds 15 per hour of sleep (in adults) and leads clinically to sleep disturbances, it 
is called PLMD.1 Approximately 70%–80% of patients with RLS show PLMS in a 
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single-night polysomnography.1 RLS is defined as an urge 
to move the legs, usually accompanied by or thought to be 
caused by uncomfortable and unpleasant sensations in the 
legs, which worsen during periods of rest, are relieved by 
movement, and occur exclusively or predominantly in the 
evening or night.1
PLMD and RLS are two different sleep disorders, but 
both are associated with PLMS and react favorably to dop-
aminergic medication, and it is assumed that they share a 
similar etiology.1,4,5 PLMD is considered to be an endopheno-
type of RLS,6 and PLMS-related gene variants are correlated 
with an increased risk of developing RLS.7 The etiology of 
idiopathic RLS and PLMD is not yet completely understood, 
but genetic predisposition and brain iron deficiency with 
abnormal dopaminergic consequences seem to play a crucial 
role.1,8 A large genome-wide association study in Iceland 
identified a genetic variant in patients with PLMS (without 
RLS) which was associated with decreased ferritin serum 
levels, and the authors discussed the possible involvement 
of iron depletion in the pathogenesis of PLMD.9
The investigation of intracortical inhibition (ICI) by 
transcranial magnetic stimulation in patients with RLS 
and PLMS points to a dysfunction of the motor system at 
a subcortical and supraspinal level.5,10 ICI is not altered by 
dysfunction of the corticospinal tract or spinal motoneurons,5 
and a cortical origin of PLMS is unlikely.4 Studies using 
single-photon emission tomography showed a decrease 
in central D2-receptor occupancy and a lower binding 
of iodobenzamide – especially in the striatal structures – 
compared to controls.11 Studies using functional magnetic 
resonance imaging (fMRI) in PLMS patients showed an 
activation in the red nuclei, brainstem, and cerebellum and 
thalamus.12 However, the cerebellar and thalamic activation 
may occur due to sensory leg discomfort, whereas the red 
nucleus and brainstem are involved in the generation of 
PLMS. Therefore, it has been suggested that these regions 
play a crucial role in the etiology of PLMS and RLS, but dif-
ferent studies showed inconsistent findings about the concise 
subcortical region.13,14
Rijsman et al described abnormal H-reflexes in PLMD 
suggesting a causative spinal disinhibition due to a 
dysfunction of descending and segmental neural pathways 
changing the excitability of the spinal motoneurons.4 In 
summary, even if the pathophysiology of PLMS is still 
unknown, the data actually suggest that PLMS may be 
generated in subcortical brain regions with disinhibited 
subcortical inputs to the cortex and simultaneous disinhibi-
tion of the spinal cord.
Little is known about the etiology of symptomatic PLMS 
and RLS in multiple sclerosis (MS). The prevalence of RLS 
in MS patients – especially in those with severe pyramidal 
and sensory disability – is four times higher than in control 
subjects,15 and studies using conventional and diffusion ten-
sor magnetic resonance imaging (MRI) show a significantly 
reduced cervical cord average fractional anisotropy in MS 
patients with RLS (compared to those without RLS),16 
whereas there was no difference between patients with and 
without RLS in the whole brain, cerebellum, and brainstem. 
It is worth noting that the MS patients with RLS showed a 
higher expanded disability status scale (EDSS)17 score than 
MS patients without RLS in this study.
In our recent cross-sectional polysomnographic study 
of patients with MS, we observed that PLMS occurred not 
only in NREM sleep but in some MS patients during REM 
sleep as well.18
PLMS in REM sleep has only been described in a few 
conditions. Telles et al reported PLMS in NREM and 
REM sleep in patients with spinal cord injury (SCI), but 
they did not mention the PLMI.19 Yokota et al investigated 
PLMS in ten patients with spinal cord damage due to 
SCI, cervical spondylosis, MS, and spinal vascular attack 
(SVA).20 The clinical manifestation and polysomnographic 
findings in these patients did not show any difference from 
typical PLMS as described in the literature, except that 
PLMs were not suppressed in REM sleep in two patients 
with complete transection of spinal cord due to SCI and 
SVA.
Outside the context of MS, SCI, and spinal cord damage, 
PLMS in REM sleep is described only in a few studies: In the 
study by Ferri et al,21 PLMI during REM sleep (REM-PLMI) 
was very low in normal controls (1.9 per hour, standard 
deviation [SD] 3.8) but higher in patients with narcolepsy 
(13.9 per hour, SD 14.8) and in patients with RLS (27.6 per 
hour, SD 35.3). Allena et al investigated 14 patients with 
bad sleep quality (only patients with PLMS in both NREM 
and REM were included) compared to 14 healthy controls 
of similar age.22 The mean REM-PLMI was 10.95 per hour 
(SD 8.51) in the PLMS group and 0.36 per hour (SD 0.93) 
in the control group. In all patients, the PLMI was higher in 
NREM than in REM. Another study described PLMS during 
REM sleep in insomnia patients as well (REM-PLMI in 
insomnia patients: 7.6 per hour, SD 10.9; REM-PLMI in 
healthy controls: 5.7 per hour, SD 8.2; REM-PLMI in RLS 
patients: 19.7 per hour, SD 39.1).23 All patients in this study 
showed substantially more PLMS during NREM sleep com-
pared with REM sleep.
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In the aforementioned studies, healthy controls and insom-
nia patients showed a mean REM-PLMI of ,10 per hour, 
whereas in patients with narcolepsy and RLS, the mean 
REM-PLMI was .10 per hour. Moreover, in all patients, 
the REM-PLMI was lower than the PLMI during NREM 
sleep.
The aim of the present work is to describe REM-associated 
PLMs in MS patients as a previously unpublished pathology 
and to investigate whether they are associated with age, sex, 
disability, and laboratory findings.
Materials and methods
The data for this retrospective analysis came from our original 
cross-sectional study18 of 66 consecutive MS patients, investi-
gated by two consecutive home-based polysomnographies.
Polysomnography
In this study, performed between 2007 and 2009, we used 
the Rechtschaffen and Kales criteria24 for classification of 
sleep stages, the Coleman criteria25 for classifying PLM, and 
the diagnostic guidelines of the Task Force of the American 
Academy of Sleep Medicine for respiratory events.26 In the 
present study, we retrospectively analyzed the polysomno-
graphic data of the second night: PLMI, REM-PLMI, PLM 
arousal index per hour of sleep (PLMI-A), sleep efficiency 
(percentage of total sleep time per time spent in bed [TiB]), 
percentage of slow wave sleep time (NREM 3 and 4) per TiB, 
percentage of NREM 1 and 2 sleep time per TiB, percentage 
of REM sleep time per TiB, sleep latency in minutes, wake 
after sleep onset in minutes, number of awakenings, apnea–
hypopnea index per hour of sleep (AHI).
ethical committee
The original study was approved by the local ethics com-
mittees, and all participants gave written informed consent 
prior to the assessment.
laboratory investigations and eDss 
values
Blood samples were analyzed for vitamin B12, ferritin, 
iron, folic acid, creatinine, thyroid-stimulating hormone, 
and glycated hemoglobin. Disability was measured with 
the EDSS.17
statistical analysis
The results were expressed as mean, SD, and range.
The correlation between PLMI and EDSS values was 
calculated using the Spearman’s coefficient. Furthermore, 
differences in EDSS values between patients with or with-
out PLMS were analyzed. Patients were classified into two 
subgroups by REM-PLMI ($10 vs ,10 PLMs per hour of 
REM sleep).
Following an exploratory analysis of the data and a (nega-
tive) check for normality of the underlying distributions, 
differences between the two subgroups regarding polysomno-
graphic parameters, age, EDSS, and laboratory findings were 
(univariately) analyzed using the Mann–Whitney U-test.
This analysis was performed in two steps: first, a univari-
ate analysis with all predictor variables; subsequently, all 
significant variables remained in the final model of multiple 
logistic regression. Odds ratios (ORs) were calculated. 
Statistical significance was established at P,0.05.
Regarding EDSS values, a receiver operating character-
istic (ROC) analysis was performed. Due to the results of 
the ROC analysis, we introduced the dichotomous variable: 
EDSS $4.0 vs ,4.0 in order to compute the OR. Afterward, 
a logistic regression was performed in order to calculate the 
outcome of this dependent variable.
All tests should be understood as constituting exploratory 
data analysis, such that neither previous power calculations 
nor subsequent adjustments for multiple testing have been 
made. Analysis was performed with SPSS software (IBM© 
SPSS© Statistics, Version 21, ©Copyright 1989, 2010 SPSS 
Inc., an IBM Company).
Results
correlation between eDss values and 
PlMi
We did not find a relationship between the PLMI (in NREM 
and REM sleep) and EDSS values (P=0.137). Moreover, 
patients suffering from PLMS with more than or equal to 
15 periodic leg movements per hour of sleep did not show 
a higher disability measured with the EDSS compared to 
patients with less than 15 periodic leg movements per hour 
of sleep (P=0.636).
Classification into different subgroups 
with respect to the reM-PlMi
Table 1 displays the demographic and polysomnographic 
data. Sixty-six MS patients (21 men and 45 women) aged 
20–66 years were classified into two subgroups according to 
the REM-PLMI ,10 per hour (group 1) or REM-PLMI $10 
per hour (group 2). Fifty-nine patients were classified into 
group 1 (14 out of these 59 patients were taking antidepres-
sants, and ten of them were suffering from RLS). The remain-
ing seven patients were classified into group 2 (none of these 
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Table 1 Differences between the two subgroups: demographic and polysomnographic parameters
All patients Group 1 Group 2 P-values
Number of patients n (%) 66 (100) 59 (89.4) 7 (10.6)
sex (male/female) n (%) 21 (31.8)/45 (68.2) 4 (6.1)/3 (4.5) 18 (27.3)/41 (62.1) 0.162
age (years) Mean ± sD 43.6±10.0 43.3±10.2 46.4±6.6 0.431
Min–max 20–66 20–66 38–57
range 25%–75% 38.75–49.0 38.5–49.0 41.5–51.0
eDss Mean ± sD 2.7±1.8 2.4±1.5 4.9±1.5 0.023
range 25%–75% 1.5–3.6 1.6–3.0 2.5–7.0
Disease-modifying therapy n (%) 50 (75.8) 44 (66.7) 6 (9.1) *
glatiramer acetate n (%) 24 (36.4) 20 (30.3) 4 (6.1)
interferon n (%) 22 (33.3) 21 (31.8) 1 (1.5)
immunoglobulins n (%) 1 (1.5) 0 (0.0) 1 (1.5)
Mitoxantrone n (%) 2 (3.0) 2 (3.0) 0 (0.0)
Natalizumab n (%) 1 (1.5) 1 (1.5) 0 (0.0)
cortisone** n (%) 2 (3.0) 2 (3.0) 0 (0.0)
No therapy n (%) 14 (21.2) 13 (19.7) 1 (1.5)
Disease course *
rrMs n (%) 46 (69.7) 42 (63.6) 4 (6.1)
sPMs n (%) 16 (24.2) 13 (19.7) 3 (4.5)
PPMs n (%) 4 (6.1) 4 (6.1) 0 (0.0)
PlMi (per hour of sleep) Mean ± sD 23.1±29.8 18.3±22.8 63.5±49.4 0.008
range 25%–75% 2.3–36.0 2.0–28.4 11.5–121.3
reM-PlMi (per hour of 
reM sleep)
Mean ± sD 6.0±18.5 1.5±2.6 44.5±41.2 ,0.0001
range 25%–75% 0.0–3.7 0.0–1.8 13.8–69.0
PlM arousal index (per 
hour of sleep)
Mean ± sD 2.7±4.2 2.3±3.9 6.6±5.1 0.030
range 25%–75% 0.2–3.6 0.2–1.9 0.8–12.7
Sleep efficiency (% TST/
TiB)
Mean ± sD 74.8±14.9 74.0±15.5 82.3±4.7 0.151
range 25%–75% 67.1–85.3 64.2–85.1 77.6–85.7
NreM 1+2 (%/TiB) Mean ± sD 51.2±12.2 50.9±12.6 54.2±7.1 0.539
range 25%–75% 43.6–62.5 41.6–62.5 48.2–62.6
NreM 3+4 (%/TiB) Mean ± sD 13.9±12.0 14.0±6.6 13.4±9.7 0.958
range 25%–75% 6.6–18.8 12.3–18.5 4.1–23.8
reM (%/TiB) Mean ± sD 14.3±7.4 14.0±7.6 16.2±5.8 0.338
range 25%–75% 10.6–17.5 10.5–17.0 11.8–21.7
sleep latency (minutes) Mean ± sD 31.9±35.7 33.4±11.0 19.3±13.0 0.307
range 25%–75% 12.5–41.0 37.4–42.0 9.6–42.0
Number of awakenings Mean ± sD 26.7±12.4 26.9±18.0 24.4±17.0 0.827
range 25%–75% 18.0–32.0 12.7–32.0 10.2–34.0
Wake after sleep onset 
(minutes)
Mean ± sD 83.8±57.3 86.4±43.0 61.9±36.0 0.539
range 25%–75% 43.0–120.0 59.7–128.0 22.2–80.0
Notes: *Due to the small sample size in the different subgroups and because of different disease-modifying therapies and different disease courses, a statistical analysis of the 
difference between different disease courses and different disease-modifying therapies was not possible. **One patient with intrathecal application of triamcinolone acetonide 
and one patient with repetitive use of pulse therapy with methylprednisolone. group 1, patients with reM-PlMi ,10 per hour; group 2, patients with reM-PlMi $10 per 
hour. P-values given in bold demonstrate a significant difference between the two subgroups.
Abbreviations: sD, standard deviation; min, minimum; max, maximum; eDss, expanded disability status scale; rrMs, relapsing–remitting multiple sclerosis; sPMs, secondary 
progressive multiple sclerosis; PPMs, primary progressive multiple sclerosis; PlMi, periodic limb movement index; reM-PlMi, PlMi during reM sleep; reM, rapid eye 
movement; TsT, total sleep time; TiB, time spent in bed; NreM, nonrapid eye movement.
seven patients were taking antidepressants or dopaminergic 
therapy; two out of these seven patients were suffering from 
comorbid RLS).
comparison of the different subgroups
Group 2 showed significantly higher EDSS values compared 
with group 1 (mean 4.9 [SD 2.5] vs 2.4 [SD 1.6]; P=0.023). 
However, there were no differences between the two groups 
with regard to the AHI, laboratory findings or age, and sex.
Polysomnographic data
The PLMI (NREM and REM) and the PLMI-A were signifi-
cantly higher in group 2 compared with group 1 (mean PLMI 
63.5 per hour of sleep [SD 49.4] vs 18.3 per hour of sleep 
[SD 22.8]; P=0.008; mean PLMI-A 6.6 per hour of sleep [SD 
5.1] vs 2.3 per hour of sleep [SD 2.3]; P=0.030).
Figure 1 shows typical REMs in electrooculograms 
(EOGs) in a 30-second epoch with REM sleep atonia in the 
chin electromyogram (EMG), whereas PLMs are present in 
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the right anterior tibial muscle (marked with a black arrow) 
during the corresponding time period.
Figure 1B shows 5 minutes of polysomnography with 
EOGs, chin EMG, both anterior tibial muscles and abdominal 
and thoracic breathing, pulsoxymetry, and snoring. The black 
frame highlights the smaller 30-second epoch as shown in 
Figure 1A. The EOG show REMs. The EEG shows alpha, 
beta, and desynchronized waves. Please note the atonia in the 
chin EMG. There are simultaneous PLMs in the right anterior 
tibial muscle (marked with a black arrow). Recordings are 
from a 39-year-old male patient with relapsing–remitting MS 
for 10 years and spasticity of both legs (EDSS =7 points). 
Prior to and following this epoch, PLMs in the left tibial 
anterior muscle were also detected.
There were no further differences between the two groups 
regarding the other polysomnographic data (sleep efficiency, 
slow wave sleep, NREM 1 and 2, REM sleep, sleep latency, 
wake after sleep onset, number of awakenings, AHI).
As only the EDSS values showed a significant difference 
between the two groups, we could not compute a multiple 
logistic regression.
Classification into two subgroups with 
respect to eDss values
We performed an ROC analysis in order to define an 
appropriate EDSS cutoff value investigating a possible rela-
tionship between disability and REM-PLMI $10 per hour. 
Of all patients with an EDSS .4.0, 89.4% showed an REM-
PLMI $10 with a sensitivity of 71.4% and a specificity of 
89.8%. The presence of more than ten PLMs per hour of REM 
sleep was in line with a greater risk of disability in EDSS (OR 
22.1; 95% confidence interval 3.5–139.7; P,0.0001). In sum, 
patients with EDSS values $4 showed a higher probability of 
presenting PLM during REM sleep (high REM-PLMI).
Discussion
The most important finding of this study is that PLMS during 
REM sleep may also occur in MS patients – and is associated 
with disability.
REM sleep is associated with the suppression of pos-
tural muscle tone (REM atonia). Whereas muscle tone and 
movement are largely absent in REM sleep, the overall brain 
activity, even in locomotor-generating regions, is maximal.27 
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Figure 1 Typical examples of PlM during reM sleep.
Notes: (A) example of PlMs during reM sleep in a 30-second polysomnographic epoch. (B) The same polysomnography with ten 30-second epochs showing PlM 
during reM.
Abbreviations: PlM, periodic limb movement; reM, rapid eye movement; eeg, electroencephalography; eMg, electromyogram; eOg, electrooculogram.
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Atonia is mediated by direct inhibition and passive disfacilita-
tion (reduced motor facilitation) of spinal motor neurons.27–29 
In the past, an aminergic–cholinergic hypothesis of REM 
sleep onset and maintenance due to a reciprocal inhibitory 
interaction between cholinergic active neurons and mono-
aminergic neurons has been replaced by the GABAergic–
glutamatergic hypothesis.30 Brainstem glutamatergic and 
GABAergic neurons play a key role in the genesis of REM 
sleep, and brainstem mechanisms play a crucial role,23,31 
but antagonism of glycine and GABA
A
 receptors does not 
prevent or even reverse REM atonia.32 Multiple inhibitory 
mechanisms seem to be responsible for triggering loss of 
activity and muscle tone during REM sleep.32
However, glutamatergic neurons of the sublaterodorsal 
tegmental nucleus generate REM sleep by their descending 
projections to medullary or spinal glycinergic/GABAergic 
premotoneurons and play a key role in the induction of 
muscle atonia during REM sleep,33 and in the animal model, 
pontine lesions and lesions of the medial medulla lead to 
REM sleep without atonia.34
In MS, spinal cord damage (especially in MS patients 
suffering from RLS) and spinal lesions are associated 
with disability quantified by the EDSS.16,35 The detection 
of REM-PLMS in more disabled MS patients argues for a 
symptomatic etiology of PLMS in these patients and against 
idiopathic PLMS.
Outside of the specific context of MS, the relationship 
between PLMS and cortical arousal in idiopathic PLMD or 
RLS has been intensely discussed.22,36 It is generally accepted 
that PLMS is associated with cortical arousals, but the tem-
poral relationship between cortical arousals and PLMS is 
still a matter of debate.37 PLMS seems not to be the trigger 
phenomenon of cortical arousal or cerebral activation, and 
several studies argue for a central (subcortical) oscillatory 
mechanism inducing cerebral activation and PLMS.22 In our 
previously published article, the increased number of PLMS 
in those MS patients suffering from PLMD or RLS has not 
been connected with an increase in PLM-related arousal.18 
Further studies should investigate the relationship between 
PLMS and cortical arousals in symptomatic PLMD/RLS in 
MS. At least the presumed pathophysiological mechanism 
of symptomatic PLMD/RLS in MS patients could explain 
the lack of PLMS-related arousal in this issue (because they 
are caused not only by a subcortical generator but also by 
spinal cord damage by spinal or brainstem lesions). In addi-
tion, a disconnection between the brain and the spinal cord 
could account for an absence of PLMS-related arousal. To 
date, however, we do not have exact data about this issue, 
and further studies combining polysomnography and MRI 
investigations are needed.
Methodical limitations
This is a retrospective data analysis. As the original study 
was performed from 2007 to 2009, we did not use the new 
2007 scoring rules from the American Academy of Sleep 
Medicine.31 Prospective polysomnographic studies using 
these scoring rules and combining the polysomnographic data 
with high-resolution MRI are needed. Another methodical 
limitation of this study is the small number of patients in 
group 2 (n=7) compared to group 1 (n=59). However, the 
value of the present work is to point out that the examination 
of PLM during REM sleep in patients with MS remains an 
important and under-recognized issue.
Conclusion
PLMs during REM sleep are associated with higher disability 
scores in MS patients, and they could represent a clinical 
feature of symptomatic PLMS. Further studies using MRI 
and polysomnography are needed.
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